You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent neuroendocrine carcinoma of the skin

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Merkel Cell Carcinoma, Neuroendocrine Carcinoma of the Skin, Trabecular Carcinoma of the Skin Trial in Tampa (Lenvatinib Oral

Recruiting
  • Merkel Cell Carcinoma
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 30, 2022

Carcinomas, Cervix Cancer, Cervical Cancer Trial in Houston (AK104)

Recruiting
  • Carcinomas
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Recurrent Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Stage I Skin Cancer Trial in Los Angeles,

Recruiting
  • Recurrent Skin Squamous Cell Carcinoma
  • +4 more
  • Cemiplimab
  • Resection
  • Los Angeles, California
  • +2 more
Nov 12, 2022

Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin Trial in Australia, United States (TH-4000)

Terminated
  • Metastatic Head-and-neck Squamous-cell Carcinoma
  • TH-4000 (Tarloxotinib)
  • Los Angeles, California
  • +9 more
Jan 9, 2023

Merkel Cell Carcinoma, Skin Cancer Trial in Boston (Cabozantinib)

Active, not recruiting
  • Merkel Cell Carcinoma
  • Skin Cancer
  • Boston, Massachusetts
  • +1 more
Jul 13, 2022

Complications and Recurrences After Mohs Micrographic Surgery

Recruiting
  • Skin Cancer
  • +9 more
  • Mohs surgery
  • Slow Mohs surgery
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Aug 23, 2023

Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Scottsdale, Arizona
  • +4 more
Nov 15, 2021

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II Trial in Australia (Avelumab, Placebo)

Recruiting
  • Merkel Cell Carcinoma
  • +5 more
  • Port Macquarie, New South Wales, Australia
  • +17 more
Aug 30, 2022

Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Tumor, Lung Non-Small Cell Squamous Carcinoma Trial in Conroe, Houston

Recruiting
  • Lung Atypical Carcinoid Tumor
  • +13 more
  • Nivolumab
  • Stereotactic Body Radiation Therapy
  • Conroe, Texas
  • +2 more
Feb 25, 2022

Carcinoma, Basal Cell Trial in Copenhagen, Roskilde (TOOsonix system ONE-M)

Recruiting
  • Carcinoma, Basal Cell
  • TOOsonix system ONE-M
  • Copenhagen, Hovedstaden, Denmark
  • +1 more
Mar 21, 2022

Head and Neck Squamous Cell Carcinoma, Skin Cancer, Metastatic Head-and-neck Squamous-cell Carcinoma Trial in Jerusalem

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Jerusalem, Israel
    Sharett institute, Hadassah University Hospital - Ein-Kerem
Nov 8, 2021

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha

Recruiting
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • +6 more
  • Omaha, Nebraska
    Urology Cancer Center/XCancer
Nov 29, 2022

Metastatic Medullary Thyroid Cancer Trial in Philadelphia (single dose of CART-GFRa4 cells, Fludarabine, Cyclophosphamide)

Recruiting
  • Metastatic Medullary Thyroid Cancer
  • single dose of CART-GFRa4 cells
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 16, 2022

Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Stanford, California
    Stanford University Medical Center
Apr 8, 2021

Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Carcinoma Trial in United States

Completed
Has Results
  • Pancreatic Alpha Cell Carcinoma
  • +4 more
  • Chicago, Illinois
  • +4 more
Jul 14, 2021

Neuroendocrine Carcinoma Trial in Beijing (Nab-paclitaxel Combined With Bevacizumab)

Recruiting
  • Neuroendocrine Carcinoma
  • Nab-paclitaxel Combined With Bevacizumab
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jan 9, 2021

Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)

Recruiting
  • Pulmonary Neuroendocrine Neoplasm
  • +9 more
  • Houston, Texas
    Excel Diagnostics and Nuclear Oncology Center
Jul 9, 2021

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

Chemo, Anti-pd-1 Antibody, Cervical Neuroendocrine Carcinoma Trial in Beijing (Drug therapy)

Recruiting
  • Chemotherapy
  • +6 more
  • Drug therapy
  • Beijing, Beijing, China
    Lei Li
Nov 15, 2020

Recurrent Cancer, Prostate Cancer, Cervical Cancer Trial in Berlin (loco-regional hyperthermia)

Recruiting
  • Recurrent Cancer
  • +9 more
  • loco-regional hyperthermia
  • Berlin, Germany
    Klinik für Radioonkologie und Strahlentherapie
May 12, 2021

Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

Recruiting
  • Adenocarcinoma
  • +75 more
  • Biomarker Testing (L)
  • +2 more
  • Idaho Falls, Idaho
  • +1 more
Oct 18, 2022

Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma Trial (Atezolizumab, Tiragolumab)

Recruiting
  • Atypical Teratoid/Rhabdoid Tumor
  • +17 more
  • Atezolizumab
  • +7 more
  • Birmingham, Alabama
  • +19 more
Feb 2, 2023